Revival Healthcare Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, Canada, Japan, Australia, Europe, Asia, Singapore, China, India, Brazil, Mexico, Kenya, South Korea, Egypt, South Africa, Nigeria, Chile, Argentina, Colombia, Peru
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Robotics
- Biotechnology
- Oncology
- Health Technology
- Health IT
- Telemedicine
- Gastroenterology
- Medical Imaging
- Surgical Instruments
- Endoscopy
Investment Size:
1,000,000 to 20,000,000 USD
Investor Details Founded: 2018
Revival Healthcare Capital is a private equity firm specializing in the medical device and diagnostic sectors of healthcare. The firm focuses on creating custom investment partnerships to pursue a broad range of opportunities, leveraging its team's extensive experience to support the growth strategies of its portfolio companies. Revival is committed to aligning its interests with those of its partners, emphasizing leadership, resources, and expertise to drive value in healthcare.
The firm's investment strategy includes a flexible capital approach, leadership in build-to-buy external innovation models, and operational capabilities. Revival's approach aims to maximize the value of external innovation, delivering on partners' most important growth objectives. The firm has a history of strategic partnerships, such as the collaboration with Olympus Corporation to co-found Swan EndoSurgical, Inc., focusing on the development of endoluminal surgical robotics.
Revival Healthcare Capital has a track record of strategic growth investments, including the closing of RVLHC II with total capital commitments of $500 million. The fund pursues strategic growth opportunities where Revival invests in high-potential target companies, allowing corporate strategic partners the option to acquire the company in the future. This strategy leverages Revival's capacity as operators and investors to build collaborative partnerships that increase corporate partners' probability of return on future growth investments and provide accelerated paths for target companies to advance innovative medical device technologies into global markets.
Requirements
- High potential target companies in the MedTech sector
- Alignment with corporate strategic partners' growth objectives
- Innovative medical device technologies with potential for global market entry
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Swan EndoSurgical
- Distalmotion
- Kardion
- Metavention
- Apollo Endosurgery
Claim this Investor
Are you an official representative of Revival Healthcare Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim